Death receptors and melanoma resistance to apoptosis

被引:184
作者
Ivanov, VN [1 ]
Bhoumik, A [1 ]
Ronai, Z [1 ]
机构
[1] CUNY Mt Sinai Sch Med, Ruttenberg Canc Ctr, New York, NY 10029 USA
关键词
melanoma; apoptosis; death receptors; Fas; TNFR-1; TRAIL;
D O I
10.1038/sj.onc.1206456
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Impaired ability to undergo programmed cell death in response to a wide range of external stimuli acquires melanomas a selective advantage for progression and metastasis as well as their notorious resistance to therapy. Better understanding of mechanisms that govern apoptosis has enabled identification of diverse routes by which melanomas manage to escape stimuli of apoptosis. Changes at genomic, transcriptional and post-translational levels of G-proteins and protein kinases (Ras, B-Raf) and their transcription factor effectors (c-Jun, ATF2, Stat3 and NF-kappaB) affects TNF, Fas and TRAIL receptors, which play important roles in acquiring melanoma's resistance to apoptosis. Here, we summarize our current understanding of changes that alters the regulation of death receptors during melanoma development.
引用
收藏
页码:3152 / 3161
页数:10
相关论文
共 125 条
[21]   Transcription factors as targets for cancer therapy [J].
Darnell, JE .
NATURE REVIEWS CANCER, 2002, 2 (10) :740-749
[22]   Mutations of the BRAF gene in human cancer [J].
Davies, H ;
Bignell, GR ;
Cox, C ;
Stephens, P ;
Edkins, S ;
Clegg, S ;
Teague, J ;
Woffendin, H ;
Garnett, MJ ;
Bottomley, W ;
Davis, N ;
Dicks, N ;
Ewing, R ;
Floyd, Y ;
Gray, K ;
Hall, S ;
Hawes, R ;
Hughes, J ;
Kosmidou, V ;
Menzies, A ;
Mould, C ;
Parker, A ;
Stevens, C ;
Watt, S ;
Hooper, S ;
Wilson, R ;
Jayatilake, H ;
Gusterson, BA ;
Cooper, C ;
Shipley, J ;
Hargrave, D ;
Pritchard-Jones, K ;
Maitland, N ;
Chenevix-Trench, G ;
Riggins, GJ ;
Bigner, DD ;
Palmieri, G ;
Cossu, A ;
Flanagan, A ;
Nicholson, A ;
Ho, JWC ;
Leung, SY ;
Yuen, ST ;
Weber, BL ;
Siegler, HF ;
Darrow, TL ;
Paterson, H ;
Marais, R ;
Marshall, CJ ;
Wooster, R .
NATURE, 2002, 417 (6892) :949-954
[23]   IAP family proteins - suppressors of apoptosis [J].
Deveraux, QL ;
Reed, TC .
GENES & DEVELOPMENT, 1999, 13 (03) :239-252
[24]   IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases [J].
Deveraux, QL ;
Roy, N ;
Stennicke, HR ;
Van Arsdale, T ;
Zhou, Q ;
Srinivasula, SM ;
Alnemri, ES ;
Salvesen, GS ;
Reed, JC .
EMBO JOURNAL, 1998, 17 (08) :2215-2223
[25]  
Devergne O, 1996, MOL CELL BIOL, V16, P7098
[26]   A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs [J].
Eichhorst, ST ;
Müller, M ;
Li-Weber, M ;
Schulze-Bergkamen, H ;
Angel, P ;
Krammer, PH .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (20) :7826-7837
[27]   Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10 [J].
Ekmekcioglu, S ;
Okcu, MF ;
Colome-Grimmer, MI ;
Owen-Schaub, L ;
Buzaid, AC ;
Grimm, EA .
MELANOMA RESEARCH, 1999, 9 (03) :261-272
[28]   The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization [J].
Elsing, A ;
Burgert, HG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :10072-10077
[29]   Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy [J].
Fan, MY ;
Chambers, TC .
DRUG RESISTANCE UPDATES, 2001, 4 (04) :253-267
[30]   The role of NF-κB in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells [J].
Franco, AV ;
Zhang, XD ;
Van Berkel, E ;
Sanders, JE ;
Zhang, XY ;
Thomas, WD ;
Nguyen, T ;
Hersey, P .
JOURNAL OF IMMUNOLOGY, 2001, 166 (09) :5337-5345